In conclusion, the main results of this study highlight that the expression of the tumor VANGL1 gene is an independent prognostic biomarker and could be considered a potential predictor for detecting malignancy risk in CRC patients. The gene discussed is VANGL1; the disease is colorectal carcinoma.